The correlation of matrix metalloproteinase 9-to-albumin ratio in wound fluid with postsurgical complications after body contouring.

Plastic and reconstructive surgery 2014 Vol.134(4) p. 530e-538e

Sexton KW, Spear M, Pollins AC, Nettey C, Greco JA, Shack RB, Hagan KF, Nanney LB

관련 도메인

Abstract

[BACKGROUND] The authors' earlier retrospective report of surgical complications after abdominal contouring surgery provided evidence that post-bariatric surgery patients are at increased risk of developing wound complications compared with a normal population. This prospective pilot study was designed as a comparative analysis of both surgical and wound healing characteristics between massive weight loss and normal patients who present for abdominal contouring surgery.

[METHODS] Excisional wounds were created and polytetrafluoroethylene tubing was inserted during the preoperative period for later harvesting in patients undergoing abdominal contouring following Roux-en-Y gastric bypass for weight loss (n = 16) or abdominoplasty (n = 17). Wound fluids were sequentially collected from drains and subjected to matrix metalloproteinase (MMP) analysis. Standard postsurgical complications were documented.

[RESULTS] Surgical complications were more common in weight loss patients (47 percent) than in control patients (25 percent). MMP analyses showed that MMP-9 levels remained significantly elevated at postoperative day 4 in patients who subsequently experienced complications in either the weight loss group (p = 0.02) or the control group (p = 0.03). Other parameters showed no significant differences between massive weight loss patients and controls.

[CONCLUSIONS] Although many markers were examined, the ratio of MMP-9 to albumin was the only predictor of postsurgical complications in any group. This lends further support to growing evidence that MMP-9 may be a useful biomarker of postsurgical complications. This pilot work showed no causal factors that explain the higher rates of postsurgical complications in the post-bariatric surgery patient population.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Risk, II.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 abdominoplasty 복부성형술 dict 1
해부 postsurgical scispacy 1
합병증 wound fluid scispacy 1
합병증 abdominal scispacy 1
합병증 wound scispacy 1
합병증 wounds scispacy 1
합병증 Wound fluids scispacy 1
약물 [BACKGROUND] scispacy 1
약물 drains scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 weight loss C1262477
Weight Loss
scispacy 1
질환 Roux-en-Y gastric scispacy 1
기타 matrix metalloproteinase 9-to-albumin scispacy 1
기타 patients scispacy 1
기타 matrix metalloproteinase scispacy 1
기타 MMP → matrix metalloproteinase scispacy 1
기타 MMP-9 scispacy 1
기타 albumin scispacy 1
기타 patient scispacy 1

MeSH Terms

Abdominoplasty; Adult; Albumins; Body Fluids; Gastric Bypass; Humans; Matrix Metalloproteinase 9; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Weight Loss

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문